Canada - Re-Export of Antisera and Other Blood Fractions
Since 2011, Canada Re-Export of Antisera and Other Blood Fractions fell by 53% year on year. At $7,520,819 in 2016, the country was number 3 comparing other countries in Re-Export of Antisera and Other Blood Fractions. Canada is overtaken by Italy, which was number 2 at $509,690,540.3 and is followed by United Arab Emirates at $2,221,861.26. United States topped the ranking with $614,613,635.05 in 2019, that is an increase of 5.9% compared to 2018. United Arab Emirates witnessed the best average annual growth at +80.6% per year, while Oman recorded the worst performance at -61.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2016 | 7,520,819.00 |
| 2015 | 18,128,586.00 |
| 2014 | 3,367,198.00 |
| 2013 | |
| 2012 |
Download all data from 2000 to 2016
How does Canada rank in Re-Export of Antisera and Other Blood Fractions?
| # | 16 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
614,613,635.05 | 2019 | +5.9 % | +3.9 % | View data |
| 2 |
#2
Italy
|
509,690,540.30 | 2019 | +7.1 % | +21.3 % | View data |
| 3 |
#3
Canada
|
7,520,819.00 | 2016 | -58.5 % | -53.0 % | View data |
| 4 |
#4
United Arab Emirates
|
2,221,861.26 | 2019 | -24.5 % | +80.6 % | View data |
| 5 |
#5
Jordan
|
1,132,890.00 | 2019 | +3.2 % | +29.7 % | View data |